Home
Search
BIO International Convention   |   June 16-19, 2025

Speakers & Presenters

All Speakers
By Count|Alphabetical
  • Show All
By Count|Alphabetical
  • Show All
By Count|Alphabetical
  • Show All
Company Type
  • Show All
Main Therapeutic Focus
  • Show All
Development Phase of Primary Product
  • Show All
Search Speakers
All Speakers
Filter by letter
A
B
C
D
E
F
G
H
I
J
K
L
M
N
O
P
Q
R
S
T
U
V
W
X
Y
Z
Results
Wallace Lin, PhD
SECRETARY-GENERAL, TAIWAN BIO
Taiwan BIO
TAIPEI, Taipei, Taiwan (Republic of China)
Bob Linke, MBA
PRESIDENT & CEO, OSMOL THERAPEUTICS, INC.
Osmol Therapeutics, Inc.
Sudbury, Massachusetts, United States
Craig Lipset
CO-CHAIR, DECENTRALIZED TRIALS & RESEARCH ALLIANCE
Meta-Collaboration to Improve Decentralized Trial Excellence: Updates from the Collaboration Landscape
San Diego, California, United States
Angus Liu
DEPUTY EDITOR, FIERCE PHARMA
Forging Biotech Alliances in China
Are We Past the Checkpoint?
Washington, DC, District of Columbia, United States
Sarah Lively, PhD
SENIOR DIRECTOR, EXTERNAL INNOVATION, DISCOVERY, PRODUCT DEVELOPMENT & SUPPLY, JOHNSON & JOHNSON
Don't Be Afraid of the Dark Genome: New Therapies from Regulatory Non-Coding RNA
David Lloyd, ACA
MANAGING DIRECTOR, SOUTHERN STAR RESEARCH
Australia
Sydney, New South Wales, Australia
Placeholder Photo
Kenneth Locke, PhD
CSO, SHANGHAI PHARMA BIOTHERAPEUTICS USA INC
Shanghai Pharmaceuticals Holding Co., Ltd
San Diego, United States
Brad Loncar
CEO, LONCAR INVESTMENTS
Biotech Hangout
Roger Longman
FOUNDER AND CHAIRMAN, REAL ENDPOINTS
Case Study: Launching Successful Gene Therapies in the Value-Based Era
Scaling Approved Patient-Centered Therapies: Resolving the Diagnostic Challenge
Prescient Diagnostics: Implications for Product Development and Reimbursement
Westport, Connecticut, United States
David Longo, MS
CEO, ORDAOS
Ordaos Bio
New York, New York, United States